RESEARCH TRIANGLE PARK, N.C. (AP) — Simulations Plus Inc. (SLP) on Thursday reported net income of $3.6 million in its fiscal ...

Completion of the transaction is expected in the fourth quarter of 2026.

Shareholders woke up to the idea that their company will have a new owner by the end of the year.

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced ...

Shareholder rights law firm Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers and directors violated securities laws and breached ...

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the ...

A “Validated” column in the DDI perpetrator table to clearly identify the values that have been validated by our DDI experts for use in simulations Dr. Michael Bolger, Founding Scientist of Simulation ...

Shares in Simulations Plus (NASDAQ: SLP) were higher by 11.65% at 11:45 a.m today as the market digested the news of a definitive agreement to be acquired by investment company Altaris for $18.50 a ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods ...